Stock Analysis of Akoya Biosciences Inc (AKYA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AKYA
Close 2.85
Change -0.0500 / 1.72 %
Volume 403061
Vol Change -244570.00 / 37.76 %
IndustryMedical Instruments & Supplies
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of Akoya Biosciences Inc


Highs/Lows of Akoya Biosciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.265 33.18 % 1.54 % 4.422.6513-May-2416-May-24
Two Week4.04 29.46 % 3.42 % 4.652.6510-May-2416-May-24
One Month3.91 27.11 % 5.60 % 4.652.6510-May-2416-May-24
Three Month5.96 52.18 % 5.95 % 6.312.6504-Mar-2416-May-24
Six Months4.33 34.18 % 17.48 % 6.312.6504-Mar-2416-May-24
One year6.12 53.43 % 27.52 % 8.82.6516-Jun-2316-May-24
Two year9.03 68.44 % 29.70 % 14.382.6504-Nov-2216-May-24


Technical View of Akoya Biosciences Inc






Charts of Akoya Biosciences Inc


Returns of Akoya Biosciences Inc with Peers
Period / StockAKYAANGOHBIOZTEKIMAB
1 Week-33.18%-0.165%-4.53%-2.54%-1.69%
1 Mth-27.11%-4.58%-17.60%2.68%-3.31%
3 Mth-52.18%-2.42%-25.44%-7.26%2.34%
6mth-34.18%-11.44%-21.26%3.60%6.06%
1 Year-53.43%-36.75%-40.14%-22.82%-47.60%
2 Year-68.44%-70.22%-9.89%-40.10%-86.22%
5 Years--69.14%42.80%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Akoya Biosciences Inc with Peers
Ratio / StockAKYAANGOHBIOZTEKIMAB
PE-1028.39-1.24-16.52-9.63-0.956
P/B450.240.6641.904.370.093
ROA-39.74-40.76-6.25-41.18-6.72
ROE-129.54-53.56-11.52-45.45-9.77
Debt To Equity1.460.1710.5200.03710.052
Revenue91365.00 K
22.05 %
316219 K
0 %
112524 K
0.716 %
72855.00
78.55 %
27644.00 K
112.48 %
Net Income-71396.00 K
1.07 %
-52442.00 K
97.54 %
-3263.00 K
65.71 %
-14414.27 K
62.75 %
-1465.69 M
39.23 %


Technicals of Akoya Biosciences Inc with Peers
Technical / StockAKYAANGOHBIOZTEKIMAB-
ADX32.4216.7530.1826.5718.60
CMF-0.179-0.199-0.271-0.130-0.329
MFI37.0474.8949.5769.0045.38
RSI27.3548.1032.7653.0842.40
MACD Abv SignalFalseTrueFalseTrueFalse
Price Above 50 MAFalseTrueFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalseTrue-


About : Akoya Biosciences Inc


Address : 100 Campus Drive, Marlborough, MA, United States, 01752
Tel : 855 896 8401
URL : https://www.akoyabio.com
Code : AKYA, ISIN : US00974H1041, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 16_Apr_2021
Employee Count : 330

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)